Click Here to return To Results

 

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010 See this aricle in Pubmed Article Abstract This trial showed the superior efficacy of oral fingolimod with respect to relapse rates and MRI outcomes in patients with multiple sclerosis, as compared with intramuscular interferon beta-1a. Longer studies are needed to assess the safety and efficacy of treatment beyond 1 year.

Related Tags

(click to filter results - removes previous filter) arrhythmia,cardiac bradycardia complications conduction block efficacy electrocardiogram,abnormal encephalitis,viral fingolimod herpes simplex encephalitis herpes zoster herpes zoster,disseminated interferon beta 1-a liver function enzymes MRI MRI,abnormal multiple sclerosis multiple sclerosis,relapsing multiple sclerosis,treatment of opportunistic infection safety treatment of neurologic disorder viral infection viral infection,CNS

Click Here to return To Results